TianhongLiMD

PubMed

• Simvastatin overcomes resistance to tyrosine kinase inhibitors in patient-derived, oncogene-driven lung adenocarcinoma models.
  Ma, W., Weijie Ma, Sixi Wei, Qianping Li, Jie Zeng, Wenwu Xiao, Chihong Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li> ;Molecular Cancer Therapeutics. 2024 Jan 18
• 3 citations
  Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.
  Arta M Monjazeb, Megan E Daly, Guillaume Luxardi, Emanual Maverakis, Alexander A Merleev, Alina I Marusina, Alexander Borowsky, Amin Mirhadi, Stephen L Shiao, Laurel B...> ;Nature Communications. 2023 Sep 2
• Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker.
  Ankit Sharma, Michael Babich, Tianhong Li, James A Radosevich> ;BMC Research Notes. 2023 Jul 6
• 1 citations
  Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer.
  Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li> ;Cancers. 2023 Feb 1
• 6 citations
  Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives.
  Luis A Godoy, Joy Chen, Jag Lally, Kyra A Toomey, Prabhu Rajappa, Roya Sheridan, Shirish Mahajan, Nicholas Stollenwerk, Chinh T Phan, Danny Cheng, Robert J Knebel, Tia...> ;Biomarker Research. 2023 Jan 18
• 19 citations
  Increasing cure rates of solid tumors by immune checkpoint inhibitors.
  Weijie Ma, Ruobing Xue, Zheng Zhu, Hizra Farrukh, Wenru Song, Tianhong Li, Lei Zheng, Chong-Xian Pan> ;Experimental Hematology & Oncology. 2023 Jan 16
• 1 citations
  Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry.
  Sixi Wei, Siqi Long, Eddie C Tian, Bridget McLaughlin, Maria Jaimes, Dennis J Montoya, Varun R Viswanath, Jeremy Chien, Qianjun Zhang, Jonathan E Van Dyke, Shuai Chen,...> ;Frontiers in Immunology. 2023 Jan 1
• Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint in...
  Ge Xiong, Richard Benjamin Young, Helen Chow, Emanual Maverakis, Ricardo A Maselli, David Paul Richman, Tianhong Li> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC.
  Matthew S Lara, Matthew A Gubens, Bianca Bacaltos, Lea Daran, Steffany L Lim, Tianhong Li, David R Gandara, Trever G Bivona, Jonathan W Riess, Collin M Blakely> ;JTO Clinical and Research Reports. 2022 Dec 1
• Interventional pulmonology use of cell-free DNA assay for metastatic non-small cell lung cancer: the UC Davis experience.
  Chinh Phan, Forrest Jespersen, Caroline Weipert, Tianhong Li, Ken Y Yoneda> ;Therapeutic Advances in Respiratory Disease. 2022 Nov 8
• 4 citations
  A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
  Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, Ai-Ming Yu, Karen Matsukuma, Thomas J Semrad, David R Gandara, Tianhong Li, Jonathan W Riess, Kit Tam, Philip C Mack, Antho...> ;Cancer Chemotherapy and Pharmacology. 2022 Sep 1
• 5 citations
  CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect.
  Mingyue Liu, Xu Wang, Xuexiang Du, Yan Zhang, Chunxia Ai, Siwen Hu-Lieskovan, Tianhong Li, Martin Devenport, Yang Liu, Pan Zheng> ;Signal Transduction and Targeted Therapy. 2022 Jul 15
• 146 citations
  Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
  John A Thompson, Bryan J Schneider, Julie Brahmer, Amaka Achufusi, Philippe Armand, Meghan K Berkenstock, Shailender Bhatia, Lihua E Budde, Saurin Chokshi, Marianne Da...> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 1
• 4 citations
  Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.
  Michael Babich, Ankit Sharma, Tianhong Li, James A Radosevich> ;Heliyon. 2022 Mar 1
• Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors.
  Richard Benjamin Young, Hemali Panchal, Shuai Chen, Aaron Steele, Andrea Iannucci, Tianhong Li, Ma, W., Weijie Ma> ;Frontiers in Oncology. 2022 Jan 1
• 4 citations
  Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC.
  Jie Zeng, Shuai Chen, Yue Lyu, Kyra Toomey, Chinh T. Phan, Ken Y. Yoneda, Tianhong Li, Ma, W., Weijie Ma> ;Biomarker Research. 2021 Sep 6
• 7 citations
  Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors
  Thomas J. Semrad, Edward J. Kim, I-Yeh Gong, Tianhong Li, Scott D Christensen, Mili Arora, Jonathan W. Riess, David R. Gandara, Karen Kelly> ;Cancer Chemotherapy and Pharmacology. 2021 May 15
• 24 citations
  Cancer neoantigens as potential targets for immunotherapy.
  Weijie Ma, Brian Pham, Tianhong Li> ;Clinical & Experimental Metastasis. 2021 May 5
• 11 citations
  Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring
  Jared C. Nesvet, Katie A. Antilla, Danielle S. Pancirer, Alexander X. Lozano, Jordan S. Preiss, Aihua Fu, Seung-min Park, Sanjiv S. Gambhir, Alice C. Fan, Joel W. Neal...> ;Clinical Chemistry. 2021 Mar 1
• 13 citations
  Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
  Caroline E. McCoach, Aiming Yu, David R. Gandara, Jonathan W. Riess, Daniel P. Vang, Tiahong Li, Primo N. Lara, Matthew A. Gubens, Frances Lara, Philip C. Mack, Laurel...> ;JCO Precision Oncology. 2021 Jan 14
• 5 citations
  Survival Trends of Metastatic Lung Cancer in California by Age at Diagnosis, Gender, Race/Ethnicity, and Histology, 1990-2014.
  Tianhong Li, Kevin Pan, Amy K. Ellinwood, Rosemary D. Cress> ;Clinical Lung Cancer. 2021 Jul 1
• 9 citations
  High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
  Qianping Li, Shuai Chen, Eddie C. Tian, Sixi Wei, Reggie R. Fan, Tao Wang, Chihong Zhou, Tianhong Li, Ma, W., Weijie Ma> ;Translational Lung Cancer Research. 2020 Jul 8
• 4 citations
  Emerging EML4-ALK Variant 5 as a Concurrent Resistance Mechanism to Osimertinib in a Patient With EGFR E19del/T790M NSCLC
  Yan Yan, Guozhong Jiang, Weijie Ma, Tianhong Li, Liping Wang> ;Clinical Lung Cancer. 2020 May 16
• Managing the Isolated Central Nervous System Progression in Patients With Oncogene-Driven Metastatic NSCLC: Does Circulating Tumor DNA Add to Management?
  Tianhong Li> ;Journal of Thoracic Oncology. 2020 Mar 1
• 60 citations
  Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer
  Julia K Rotow, Philippe Gui, Wei Wu, Victoria M. Raymond, Richard B. Lanman, Frederic J. Kaye, Nir Peled, Ferran Fece de la Cruz, Brandon Nadres, Ryan B. Corcoran, Iwe...> ;Clinical Cancer Research. 2020 Jan 15
• Join now to see all